These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16443774)

  • 1. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations.
    Brackenridge A; Pearson ER; Shojaee-Moradie F; Hattersley AT; Russell-Jones D; Umpleby AM
    Diabetes; 2006 Feb; 55(2):405-11. PubMed ID: 16443774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.
    Surmely JF; Guenat E; Philippe J; Dussoix P; Schneiter P; Temler E; Vaxillaire M; Froguel P; Jéquier E; Tappy L
    Diabetes; 1998 Sep; 47(9):1459-63. PubMed ID: 9726235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
    Pearson ER; Badman MK; Lockwood CR; Clark PM; Ellard S; Bingham C; Hattersley AT
    Diabetes Care; 2004 May; 27(5):1102-7. PubMed ID: 15111528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3).
    Guenat E; Seematter G; Philippe J; Temler E; Jéquier E; Tappy L
    Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants.
    Kitanaka S; Sato U; Igarashi T
    J Endocrinol; 2007 Jan; 192(1):141-7. PubMed ID: 17210751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HNF-4alpha (MODY1), HNF-1beta (MODY5), and HNF-1alpha (MODY3) proteins in the developing mouse pancreas.
    Nammo T; Yamagata K; Tanaka T; Kodama T; Sladek FM; Fukui K; Katsube F; Sato Y; Miyagawa J; Shimomura I
    Gene Expr Patterns; 2008 Jan; 8(2):96-106. PubMed ID: 17996499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
    Baier LJ; Permana PA; Traurig M; Dobberfuhl A; Wiedrich C; Sutherland J; Thuillez P; Luczy-Bachman G; Hara M; Horikawa Y; Hinokio Y; Hanson RL; Bogardus C
    Diabetes Care; 2000 Mar; 23(3):302-4. PubMed ID: 10868855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.
    Okita K; Yang Q; Yamagata K; Hangenfeldt KA; Miyagawa J; Kajimoto Y; Nakajima H; Namba M; Wollheim CB; Hanafusa T; Matsuzawa Y
    Biochem Biophys Res Commun; 1999 Sep; 263(2):566-9. PubMed ID: 10491332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant HNF-1alpha and mutant HNF-1beta identified in MODY3 and MODY5 downregulate DPP-IV gene expression in Caco-2 cells.
    Gu N; Adachi T; Matsunaga T; Takeda J; Tsujimoto G; Ishihara A; Yasuda K; Tsuda K
    Biochem Biophys Res Commun; 2006 Aug; 346(3):1016-23. PubMed ID: 16781669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.
    Stride A; Ellard S; Clark P; Shakespeare L; Salzmann M; Shepherd M; Hattersley AT
    Diabetes Care; 2005 Jul; 28(7):1751-6. PubMed ID: 15983330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
    Pontoglio M; Sreenan S; Roe M; Pugh W; Ostrega D; Doyen A; Pick AJ; Baldwin A; Velho G; Froguel P; Levisetti M; Bonner-Weir S; Bell GI; Yaniv M; Polonsky KS
    J Clin Invest; 1998 May; 101(10):2215-22. PubMed ID: 9593777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.
    Frayling TM; Evans JC; Bulman MP; Pearson E; Allen L; Owen K; Bingham C; Hannemann M; Shepherd M; Ellard S; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S94-100. PubMed ID: 11272211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mutations in HNF-1alpha and HNF-1beta on the transcriptional regulation of human sucrase-isomaltase in Caco-2 cells.
    Gu N; Suzuki N; Takeda J; Adachi T; Tsujimoto G; Aoki N; Ishihara A; Tsuda K; Yasuda K
    Biochem Biophys Res Commun; 2004 Dec; 325(1):308-13. PubMed ID: 15522234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.
    Kim KA; Kang K; Chi YI; Chang I; Lee MK; Kim KW; Shoelson SE; Lee MS
    Diabetologia; 2003 May; 46(5):721-7. PubMed ID: 12712243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
    Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
    Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.